GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » China Vanke Co Ltd (HKSE:02202) » Definitions » Research & Development

China Vanke Co (HKSE:02202) Research & Development : HK$567 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is China Vanke Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. China Vanke Co's Research & Development for the three months ended in Mar. 2024 was HK$150 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was HK$567 Mil.


China Vanke Co Research & Development Historical Data

The historical data trend for China Vanke Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Vanke Co Research & Development Chart

China Vanke Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,186.95 789.13 786.56 765.91 586.25

China Vanke Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 173.17 144.60 171.63 100.36 150.04

China Vanke Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$567 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Vanke Co  (HKSE:02202) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


China Vanke Co Research & Development Related Terms

Thank you for viewing the detailed overview of China Vanke Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


China Vanke Co (HKSE:02202) Business Description

Traded in Other Exchanges
Address
Vanke Center, No. 33 Huanmei Road, Dameisha, Yantian District, Shenzhen, CHN, 518083
China Vanke is a large real estate developer in China with residential property sales among the top three of all peers through the past five years. While property development accounts for most of its revenue and earnings, it has expanded its business presence in investment properties such as commercial retail complexes, long-term leasing apartments, and leasable logistical assets. China Vanke also owns an over-60% equity interest in its property management division Onewo, which manages the second-largest gross floor area in China. It is dual-listed in Shenzhen and Hong Kong, and state-owned Shenzhen Metro is the largest shareholder with a 27.2% stake.
Executives
Blackrock, Inc. 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co. 2102 Investment manager
Shang Hai Ning Quan Zi Chan Guan Li You Xian Gong Si 2102 Investment manager
Morgan Stanley 2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co. 2502 Approved lending agent
Gic Private Limited 2102 Investment manager
Ubs Group Ag 2201 Interest of corporation controlled by you
Shen Zhen Ying An Cai Wu Gu Wen You Xian Gong Si 2201 Interest of corporation controlled by you

China Vanke Co (HKSE:02202) Headlines

No Headlines